Picture of Pluri logo

PLUR — Pluri News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Pluristem Says Co Has Developed Serum-Free Formulation To Support Manufacturing Of Cell Therapy Products

June 17 (Reuters) - Pluristem Therapeutics Inc  PSTI.O :
    * PLURISTEM THERAPEUTICS INC - COMPANY HAS DEVELOPED A
SERUM-FREE
FORMULATION TO SUPPORT MANUFACTURING OF CELL THERAPY PRODUCTS

Source text for Eikon:  ID:nGNX4yyRvy 
Further company coverage:  PSTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Pluri

See all news